These compounds may interact with:
Serine/threonine-protein kinase Chk1
Potentially involved in: carcinoma; cancer; ataxia telangiectasia; seckel syndrome; aplastic anemia; nijmegen breakage syndrome; polyploidy; schizophrenia; mammary neoplasms; adrenocortical carcinoma; adult high grade glioma; atopic dermatitis; atypical teratoid / rhabdoid tumor; breast cancer; colon cancer; cystic fibrosis; ductal carcinoma in situ; endometriosis; ependymoma; glioblastoma
Disease data sourced from Pharos.